PREGNANCY IN POLYCYSTIC OVARY SYNDROME II

多囊卵巢综合症 II 的妊娠

• 批准号: 7951306
• 负责人: RICHARD S. LEGRO
• 金额: $ 1.16万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2010-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951306
• 关键词: Clinical Research; Clomiphene; Computer Retrieval of Information on Scientific Projects Database; Fertility; Funding; Grant; Institution; Letrozole; Live Birth; Ovarian; Patients; Polycystic Ovary Syndrome; Pregnancy; Protocols documentation; Randomized; Research; Research Personnel; Resources; Source; Syndrome; United States National Institutes of Health; Woman

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a multi-center protocol examining the effects of Clomiphene as opposed to Letrozole in the promotion of fertility in women with polycystic ovarian syndrome. A total of 750 patients will be randomized across a number of centers. The primary study endpoint is live birth after randomization to one or the other therapy.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这是一项多中心研究方案，旨在研究克罗米芬与来曲唑在促进多囊卵巢综合征妇女生育方面的作用。共有750例患者将在多个研究中心随机分配。主要研究终点是随机分配至一种或另一种治疗后的活产。